KENNETH BLANKSTEIN M.D. NPI 1184612566

NPI Information

  • NPI: 1184612566
  • Provider Name: KENNETH BLANKSTEIN, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 2100 WESCOTT DR
    FLEMINGTON, NJ
    ZIP 08822
  • Phone: (908) 788-6461

Map and Directions

Get Directions

NPI Details

Kenneth Blankstein, M.D. is a hematology and oncology internal medicine in Flemington, NJ with 41 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Kenneth Blankstein, M.D. NPI is 1184612566. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: NEW YORK MEDICAL COLLEGE
Graduation Year:1984

The provider's business location address is:

2100 WESCOTT DR
FLEMINGTON, NJ
ZIP 08822-603
Phone: (908) 788-6461
Fax: (908) 237-2352

The NPI 1184612566 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, granisetron, extended-release, 0.1 mg (HCPCS:J1627)
  • Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg (HCPCS:Q5111)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Magnesium level (HCPCS:83735)
  • Phosphate level (HCPCS:84100)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Unclassified drugs (HCPCS:J3490)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Initial hospital observation care per day, typically 50 minutes (HCPCS:99219)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Vitamin d-3 level (HCPCS:82306)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Blood creatinine level (HCPCS:82565)
  • Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
  • Calcium level, total (HCPCS:82310)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)

The enumeration date for this NPI number is 10/11/2005 and was last updated on 12/30/2008.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyMA54491NEW JERSEYYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1521209NLUMEDICARE ID-TYPE UNSPECIFIEDNEW JERSEY
20847305MEDICAIDNEW JERSEY
3E75328MEDICARE UPINNEW JERSEY

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.